Skip to Content

Tag: Inolife


Also Noted

Inolife primes ADW to distribute Inojex

April 17, 2018HME News Staff

TORONTO - Inolife R&D has entered into a letter of intent with ADW Diabetes for the distribution of its Inojex, a patented and FDA-cleared needle-free injection device. With ADW as a new partner, Inolife will have strategic access to one of the biggest insulin markets in the world, according to a press release. “By connecting innovative needle-free insulin delivery technologies to ADW's diabetic community, we will create new opportunities and synergies that otherwise would not have been available...

ADW, blood glucose, diabetes, Inolife, needle-free


Read Full Articlered right arrow icon